Levetiracetam Arrow

Levetiracetam, the active ingredient in Levetiracetam Arrow, is an antiepileptic presented as a tablet for oral use. It is used to control partial‑onset seizures and generalized tonic‑clonic seizures in patients diagnosed with epilepsy.

GNH USA supplies Levetiracetam Arrow as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that acts on neuronal excitability to reduce seizure activity. - Partial‑onset seizures: helps achieve seizure freedom or significant reduction in seizure frequency. - Generalized tonic‑clonic seizures: provides control of convulsive episodes in adult and pediatric patients. - Myoclonic seizures: used as adjunct therapy to lessen myoclonic jerks in juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Dizziness: sensation of light‑headedness or imbalance. - Irritability: mood changes including increased agitation. - Nausea: mild stomach upset or queasiness.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression or suicidal thoughts. - Hematologic abnormalities: low blood cell counts such as neutropenia.

Before initiating therapy, clinicians should consider several safety aspects. - Renal function: adjust dose in patients with impaired clearance. - Psychiatric history: monitor for mood changes or depression. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy and lactation: evaluate benefit‑risk ratio as data are limited. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma levels, reducing seizure control. - Phenobarbital: can also decrease levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Sedative agents (e.g., benzodiazepines): may enhance central nervous system depression. - Antidepressants: watch for additive mood‑related side effects. - Oral contraceptives: monitor for potential reduced contraceptive effectiveness.